search
info Über APA-OTS photo_camera Aktuelle Bilder play_arrow Aktuelle Videos event Aktuelle Termine search Suche Alle AussendungenPolitikWirtschaftFinanzenChronikKulturMedienKarriereTourismusBundesländer

Isomorphic Labs

search Suche in Pressroom
Aussendungen
Kontaktpersonen
  • Aussender Logo
  • Isomorphic Labs
Isomorphic Labs appoints Dr. Ben Wolf as Chief Medical Officer and establishes US Presence

London and Boston (OTE) - Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into life-changing medicines.

  • 17.06.2025, 13:33:02
  • /
  • OTE0004
  • Isomorphic Labs
Isomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance therapeutic progra

London (OTE) - Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline.

  • 31.03.2025, 13:30:03
  • /
  • OTE0002
  • Isomorphic Labs
Isomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance therapeutic progra

London (OTE) - Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline.

  • 31.03.2025, 13:30:02
  • /
  • OTE0001
  • Zurück page
  • 1 / 1
  • You're on page 1
  • Weiter page
>

So erreichen Sie uns

APA-Comm GmbH
Laimgrubengasse 10
1060 Wien, Österreich

PR-Desk Support
Tel. +43 1 36060-5310

APA-Salesdesk
Tel. +43 1 36060-1234

comm@apa.at

Services

PR-Desk
APA-OTS-Video
APA-Fotoservice
Cookie-Präferenzen


OTS-App
Bild mit den Logo und Schriftzug vom Google Play Store
Bild mit den Logo und Schriftzug von Apples App Store
Channels

Politik
Wirtschaft
Finanzen
Chronik
Kultur
Medien
Karriere
Tourismus

Bleiben Sie informiert

OTS-Mailabo
APA-Blog


Newsletter Abonnieren
© 1997 - 2025 APA-Comm GmbH und der jeweilige Aussender. Alle Rechte vorbehalten.
Hilfe / Datenschutz / Impressum / Offenlegung / AGB / Cookie-Präferenzen / Copyright